Medistim ASA (FRA:MD1)

Market Cap	338.88M +15.0%
Revenue (ttm)	59.12M +25.8%
Net Income	13.45M +53.3%
EPS	0.74 +53.6%
Shares Out	n/a
PE Ratio	25.19
Forward PE	24.53
Dividend	0.51 (2.76%)
Ex-Dividend Date	May 9, 2025

Volume	n/a
Average Volume	73
Open	18.70
Previous Close	18.35
Day's Range	18.70 - 18.70
52-Week Range	13.05 - 24.40
Beta	n/a
RSI	50.51
Earnings Date	Apr 9, 2026

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1984
• Employees: 154
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MD1

Financial Performance

In 2025, Medistim ASA's revenue was 699.77 million, an increase of 25.82% compared to the previous year's 556.16 million. Earnings were 159.21 million, an increase of 53.33%.

Financial numbers in NOK